1. Biogen earnings + surprise news about Alzheimer’s drug aducanumab — Bristol-Myers makes Opdivo pitch for frontline lung cancer — Criticism of ProPublica’s latest analysis of physician payment data — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Upcoming Training Meeting

Discussion in 'Ista Pharma' started by Anonymous, Jul 4, 2012 at 8:38 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    I just heard they are flying our Reps out early to help with training. Is that right? We are training their trainers? Funny!!!
     
  2. Anonymous

    Anonymous Guest

    Bring that attitude to the meeting and teach us the "rocket science" of selling Bromday! Or maybe a "breakout" session on creating PDF files (post-op sheets). You have a good NSAID that is dosed less often than Nevanac and Allergan shot themselves in the foot with Accuvail. You (Ista) were willing to create sheets and fund thousands of dollars of printing in every territory when AA decided to get out of that business (similar to AA pull out of antibiotic business). Smart move on your part, but please don't act like every account you gained was due to superior, clinical "salesmanship"! Do you have good sales people? Yes. So do we! Its time to move forward or move on to greener pastures. See ya in FL
     
  3. Anonymous

    Anonymous Guest

    You we're printers/ that was it/ it's over/ Bromday is History/ the only thing that validated your price was the pre and post op sheets. Do you want to go to jail?